Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Massimo Cristofanilli | Researchclopedia

Back to researchers

Massimo Cristofanilli

Northwestern University ORCID

1,439

Works

57,470

Citations

111

h-index

426

i10-index

Research Topics

Cancer Cells and Metastasis Cancer Genomics and Diagnostics Advanced Breast Cancer Therapies

Affiliations

Université Paris-Sud2019–2019

Rutgers, The State University of New Jersey2016–2016

Università Cattolica del Sacro Cuore2016–2016

Tunis University2022–2022

Northwestern University2015–2025

Top Works

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Massimo Cristofanilli,G. Thomas Budd,et al.

20044,564 citations

HER2/EGFR in Cancer Research

Breast Cancer Treatment Studies

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

Cornelia Liedtke,Chafika Mazouni,et al.

20082,876 citations

Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

Roman Rouzier,Charles M. Perou,et al.

20051,881 citations

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

Massimo Cristofanilli,Nicholas C. Turner,et al.

20161,799 citations

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

Nicholas C. Turner,Jungsil Ro,et al.

20151,569 citations

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

Sabine Riethdorf,Herbert A. Fritsche,et al.

20071,331 citations

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

Nicholas C. Turner,Dennis J. Slamon,et al.

20181,264 citations

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Aman U. Buzdar,Nuhad K. Ibrahim,et al.

20051,165 citations

Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

Massimo Cristofanilli,Daniel F. Hayes,et al.

20051,131 citations